The development
What happened
Google DeepMind's October 15 walkthrough introduces a Biomolecular Structure Viewer inside Antigravity. Scientists and an AI agent share a 3D view while investigating antimicrobial peptide hypotheses; the highlighted candidates still need laboratory validation.
Key facts
Researchers' highlights and annotations are synchronized back to the agent, allowing discussion of the same structural context.
Antigravity brings database queries, structural comparisons and literature review into an interactive workspace; ProtNLM contributes predicted protein-function annotations.
Scientists set research strategy and interpret evidence, while the agent handles supporting searches and analyses.
The featured lead and other candidates are undergoing wet-lab validation. The walkthrough does not establish measured efficacy, toxicity safety or an approved antibiotic.
The context
Why it matters
A shared visual workspace may reduce friction between research tools and make hypotheses easier to inspect. Computational plausibility still requires experimental testing; this demonstration does not prove universal speed gains or successful drug development.